Promising New Drug for Migraine Prevention

by | Oct 9, 2014 | Headache Drugs

A new phase 2 trial of ALD403, a humanized monoclonal antibody directed against calcitonin gene-related peptide (CGRO) showed that the drug was safe and effective. Although preliminary, the results are promising, said lead author, David W. Dodick, professor,...

Pin It on Pinterest